Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2021

Open Access 01-12-2021 | Systemic Lupus Erythematosus | Research

HPyV6 and HPyV7 in urine from immunocompromised patients

Authors: Carla Prezioso, Marijke Van Ghelue, Ugo Moens, Valeria Pietropaolo

Published in: Virology Journal | Issue 1/2021

Login to get access

Abstract

Background

Human polyomavirus 6 (HPyV6) and HPyV7 are two of the novel polyomaviruses that were originally detected in non-diseased skin. Serological studies have shown that these viruses are ubiquitous in the healthy adult population with seroprevalence up to 88% for HPyV6 and 72% for HPyV7. Both viruses are associated with pruritic skin eruption in immunocompromised patients, but a role with other diseases in immunoincompetent patients or malignancies has not been established.

Methods

PCR was used to determine the presence of HPyV6 and HPyV7 DNA in urine samples from systemic lupus erythematosus (n = 73), multiple sclerosis (n = 50), psoriasis vulgaris (n = 15), arthritic psoriasis (n = 15) and HIV-positive patients (n = 66). In addition, urine from pregnant women (n = 47) and healthy blood donors (n = 20) was investigated.

Results

HPyV6 DNA was detected in 21 (28.8%) of the urine specimens from SLE patients, in 6 (9.1%) of the urine samples from the HIV-positive cohort, and in 19 (40.4%) samples from pregnant women. HPyV7 DNA was only found in 6 (8.2%) of the urine specimens from SLE patients and in 4 (8.5%) samples from pregnant women. No HPyV6 and HPyV7 viruria was detected in the urine samples from the other patients.

Conclusions

HPyV6, and to a lesser extend HPyV7, viruria seems to be common in SLE and HIV-positive patients, and pregnant women. Whether these viruses are of clinical relevance in these patients is not known.
Literature
1.
Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med. 1953;83:414–21.CrossRefPubMed
2.
Buck CB, Van Doorslaer K, Peretti A, Geoghegan EM, Tisza MJ, An P, Katz JP, Pipas JM, McBride AA, Camus AC, et al. The ancient evolutionary history of polyomaviruses. PLoS Pathog. 2016;12:e1005574.PubMedPubMedCentralCrossRef
3.
Calvignac-Spencer S, Feltkamp MC, Daugherty MD, Moens U, Ramqvist T, Johne R, Ehlers B. A taxonomy update for the family Polyomaviridae. Arch Virol. 2016;161:1739–50.PubMedCrossRef
4.
Moens U, Krumbholz A, Ehlers B, Zell R, Johne R, Calvignac-Spencer S, Lauber C. Biology, evolution, and medical importance of polyomaviruses: an update. Infect Genet Evol. 2017;54:18–38.PubMedCrossRef
5.
Moens U, Van Ghelue M, Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci. 2007;64:1656–78.PubMedCrossRef
6.
Topalis D, Andrei G, Snoeck R. The large tumor antigen: a “Swiss Army knife” protein possessing the functions required for the polyomavirus life cycle. Antivir Res. 2013;97:122–36.PubMedCrossRef
7.
Baez CF, Brandão Varella R, Villani S, Delbue S. Human polyomaviruses: the battle of large and small tumor antigens. Virology (Auckl). 2017;8:1178122–17744785.
8.
Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971;1:1257–60.PubMedCrossRef
9.
Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1:1253–7.PubMedCrossRef
10.
Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA, Dalianis T, Ramqvist T, Andersson B. Identification of a third human polyomavirus. J Virol. 2007;81:4130–6.PubMedPubMedCentralCrossRef
11.
Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, Brennan DC, Storch GA, Sloots TP, Wang D. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 2007;3:e64.PubMedPubMedCentralCrossRef
12.
13.
Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe. 2010;7:509–15.PubMedPubMedCentralCrossRef
14.
van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog. 2010;6:e1001024.PubMedPubMedCentralCrossRef
15.
Gheit T, Dutta S, Oliver J, Robitaille A, Hampras S, Combes JD, McKay-Chopin S, Le Calvez-Kelm F, Fenske N, Cherpelis B, et al. Isolation and characterization of a novel putative human polyomavirus. Virology. 2017;506:45–54.PubMedCrossRef
16.
Scuda N, Hofmann J, Calvignac-Spencer S, Ruprecht K, Liman P, Kühn J, Hengel H, Ehlers B. A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol. 2011;85:4586–90.PubMedPubMedCentralCrossRef
17.
18.
Lim ES, Reyes A, Antonio M, Saha D, Ikumapayi UN, Adeyemi M, Stine OC, Skelton R, Brennan DC, Mkakosya RS, et al. Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology. 2013;436:295–303.PubMedCrossRef
19.
Ondov BD, Starrett GJ, Sappington A, Kostic A, Koren S, Buck CB, Phillippy AM. Mash Screen: high-throughput sequence containment estimation for genome discovery. Genome Biol. 2019;20:232.PubMedPubMedCentralCrossRef
20.
Korup S, Rietscher J, Calvignac-Spencer S, Trusch F, Hofmann J, Moens U, Sauer I, Voigt S, Schmuck R, Ehlers B. Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLoS ONE. 2013;8:e58021.PubMedPubMedCentralCrossRef
21.
Mishra N, Pereira M, Rhodes RH, An P, Pipas JM, Jain K, Kapoor A, Briese T, Faust PL, Lipkin WI. Identification of a novel polyomavirus in a pancreatic transplant recipient with retinal blindness and vasculitic myopathy. J Infect Dis. 2014;210:1595–9.PubMedPubMedCentralCrossRef
22.
Doerries K. Human polyomavirus JC and BK persistent infection. Adv Exp Med Biol. 2006;577:102–16.PubMedCrossRef
23.
24.
Leung AY, Yuen KY, Kwong YL. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant. 2005;36:929–37.PubMedCrossRef
25.
Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation. 2009;87:621–30.PubMedCrossRef
26.
Yang D, Keys B, Conti D, Foulke L, Stellrecht K, Cook L, Lopez-Soler RI. JC polyomavirus nephropathy, a rare cause of transplant dysfunction: case report and review of literature. Transpl Infect Dis. 2017;19(2):12654.CrossRef
27.
28.
Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2020;17(1):37–51.PubMedCrossRefPubMedCentral
29.
Kazem S, van der Meijden E, Feltkamp MC. The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications. APMIS. 2013;121:770–2.PubMedCrossRef
30.
Nicol JT, Robinot R, Carpentier A, Carandina G, Mazzoni E, Tognon M, Touzé A, Coursaget P. Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol. 2013;20:363–8.PubMedPubMedCentralCrossRef
31.
van der Meijden E, Bialasiewicz S, Rockett RJ, Tozer SJ, Sloots TP, Feltkamp MC. Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. PLoS ONE. 2013;8:e81078.PubMedPubMedCentralCrossRef
32.
Robles C, Casabonne D, Benavente Y, Costas L, Gonzalez-Barca E, Aymerich M, Campo E, Tardon A, Jiménez-Moleón JJ, Castaño-Vinyals G, et al. Seroreactivity against Merkel cell polyomavirus and other polyomaviruses in chronic lymphocytic leukaemia, the MCC-Spain study. J Gen Virol. 2015;96:2286–92.PubMedCrossRef
33.
Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M, Farzan SF, Hoen AG, Christensen BC, Kelsey KT, Marsit CJ, et al. Seroepidemiology of human polyomaviruses in a US population. Am J Epidemiol. 2016;183:61–9.PubMedCrossRef
34.
Kamminga S, van der Meijden E, Feltkamp MCW, Zaaijer HL. Seroprevalence of fourteen human polyomaviruses determined in blood donors. PLoS ONE. 2018;13:e0206273.PubMedPubMedCentralCrossRef
35.
Foulongne V, Sauvage V, Hebert C, Dereure O, Cheval J, Gouilh MA, Pariente K, Segondy M, Burguière A, Manuguerra JC, et al. Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS ONE. 2012;7:e38499.PubMedPubMedCentralCrossRef
36.
Wieland U, Silling S, Hellmich M, Potthoff A, Pfister H, Kreuter A. Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. J Gen Virol. 2014;95:928–32.PubMedCrossRef
37.
Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch GA, Weinstock GM. Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol. 2014;12:71.PubMedPubMedCentralCrossRef
38.
Hampras SS, Giuliano AR, Lin HY, Fisher KJ, Abrahamsen ME, McKay-Chopin S, Gheit T, Tommasino M, Rollison DE. Natural history of polyomaviruses in men: the HPV infection in men (HIM) study. J Infect Dis. 2015;211:1437–46.PubMedCrossRef
39.
Fava P, Merlino C, Novelli M, Ponti R, Galliano I, Montanari P, Tovo PA, Fierro MT, Bergallo M. HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects. J Eur Acad Dermatol Venereol. 2016;30:624–7.PubMedCrossRef
40.
Franzén J, Ramqvist T, Bogdanovic G, Grün N, Mattson J, Dalianis T. Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis. Transpl Infect Dis. 2016;18:240–6.PubMedCrossRef
41.
Siebrasse EA, Bauer I, Holtz LR, Le BM, Lassa-Claxton S, Canter C, Hmiel P, Shenoy S, Sweet S, Turmelle Y, et al. Human polyomaviruses in children undergoing transplantation, United States, 2008–2010. Emerg Infect Dis. 2012;18:1676–9.PubMedPubMedCentralCrossRef
42.
Delbue S, Franciotta D, Giannella S, Dolci M, Signorini L, Ticozzi R, D’Alessandro S, Campisciano G, Comar M, Ferrante P, et al. Human polyomaviruses in the cerebrospinal fluid of neurological patients. Microorganisms. 2019;8:16.PubMedCentralCrossRef
43.
Delbue S, Elia F, Signorini L, Bella R, Villani S, Marchioni E, Ferrante P, Phan TG, Delwart E. Human polyomavirus 6 DNA in the cerebrospinal fluid of an HIV-positive patient with leukoencephalopathy. J Clin Virol. 2015;68:24–7.PubMedCrossRef
44.
45.
Zheng WZ, Wei TL, Ma FL, Yuan WM, Zhang Q, Zhang YX, Cui H, Zheng LS. Human polyomavirus type six in respiratory samples from hospitalized children with respiratory tract infections in Beijing, China. Virol J. 2015;12:166.PubMedPubMedCentralCrossRef
46.
Rascovan N, Monteil Bouchard S, Grob JJ, Collet-Villette AM, Gaudy-Marqueste C, Penicaud M, Lepidi H, Raoult D, Desnues C. Human polyomavirus-6 infecting lymph nodes of a patient with an angiolymphoid hyperplasia with eosinophilia or Kimura disease. Clin Infect Dis. 2016;62:1419–21.PubMedCrossRef
47.
Aboudar S, Salmona M, De Masson A, Rivet J, Cardot-Leccia N, Mercier-Delarue S, Ram-Wolff C, Garnier G, Bouaziz JD, Lebbé C, et al. Diversity and compartmentalization of human polyomavirus 7 in a patient with dyskeratotic dermatosis. J Eur Acad Dermatol Venereol. 2020;34:e609–12.PubMedCrossRef
48.
Kolia-Diafouka P, Foulongne V, Boulle N, Ngou J, Kelly H, Sawadogo B, Delany-Moretlwe S, Mayaud P, Segondy M. Detection of four human polyomaviruses (MCPyV, HPyV6, HPyV7 and TSPyV) in cervical specimens from HIV-infected and HIV-uninfected women. Sex Transm Infect. 2016;92:492–4.PubMedCrossRef
49.
Ho J, Jedrych JJ, Feng H, Natalie AA, Grandinetti L, Mirvish E, Crespo MM, Yadav D, Fasanella KE, Proksell S, et al. Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. J Infect Dis. 2015;211:1560–5.PubMedCrossRef
50.
Nguyen KD, Lee EE, Yue Y, Stork J, Pock L, North JP, Vandergriff T, Cockerell C, Hosler GA, Pastrana DV, et al. Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses. J Am Acad Dermatol. 2017;76:932–40.PubMedCrossRef
51.
Canavan TN, Baddley JW, Pavlidakey P, Tallaj JA, Elewski BE. Human polyomavirus-7-associated eruption successfully treated with acitretin. Am J Transplant. 2018;18:1278–84.PubMedCrossRef
52.
Smith SDB, Erdag G, Cuda JD, Rangwala S, Girardi N, Bibee K, Orens JB, Prono MD, Toptan T, Loss MJ. Treatment of human polyomavirus-7-associated rash and pruritus with topical cidofovir in a lung transplant patient: case report and literature review. Transpl Infect Dis. 2018;20(1):e12793.CrossRef
53.
Rosenstein RK, Pastrana DV, Starrett GJ, Sapio MR, Hill NT, Jo JH, Lee CR, Iadarola MJ, Buck CB, Kong HH et al. Host-pathogen interactions in human polyomavirus 7 (HPyV7)-associated pruritic skin eruption. J Investig Dermatol. 2020;S0022–202x(20)32145-X.
54.
Hashida Y, Higuchi T, Nakajima S, Nakajima K, Ujihara T, Kabashima K, Sano S, Daibata M. Human polyomavirus 6 detected in cases of eosinophilic pustular folliculitis. J Infect Dis. 2020;jiaaa607.
55.
Hashida Y, Higuchi T, Nakajima K, Ujihara T, Murakami I, Fujieda M, Sano S, Daibata M. Human polyomavirus 6 with the Asian-Japanese genotype in cases of kimura disease and angiolymphoid hyperplasia with eosinophilia. J Investig Dermatol. 2020;140:1650–3.PubMedCrossRef
56.
Zanotta N, Delbue S, Signorini L, Villani S, D’Alessandro S, Campisciano G, Colli C, De Seta F, Ferrante P, Comar M. Merkel cell polyomavirus is associated with anal infections in men who have sex with men. Microorganisms. 2019;7:54.PubMedCentralCrossRef
57.
Schrama D, Buck CB, Houben R, Becker JC. No evidence for association of HPyV6 or HPyV7 with different skin cancers. J Investig Dermatol. 2012;132:239–41.PubMedCrossRef
58.
Scola N, Wieland U, Silling S, Altmeyer P, Stücker M, Kreuter A. Prevalence of human polyomaviruses in common and rare types of non-Merkel cell carcinoma skin cancer. Br J Dermatol. 2012;167:1315–20.PubMedCrossRef
59.
Imajoh M, Hashida Y, Nakajima H, Sano S, Daibata M. Prevalence and viral DNA loads of three novel human polyomaviruses in skin cancers from Japanese patients. J Dermatol. 2013;40:657–60.PubMedCrossRef
60.
Schrama D, Groesser L, Ugurel S, Hafner C, Pastrana DV, Buck CB, Cerroni L, Theiler A, Becker JC. Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations. JAMA Dermatol. 2014;150:1180–6.PubMedCrossRefPubMedCentral
61.
Frouin E, Guillot B, Larrieux M, Tempier A, Boulle N, Foulongne V, Girard C, Costes V, Solassol J. Cutaneous epithelial tumors induced by vemurafenib involve the MAPK and Pi3KCA pathways but not HPV nor HPyV viral infection. PLoS ONE. 2014;9:e110478.PubMedPubMedCentralCrossRef
62.
Beckervordersandforth J, Pujari S, Rennspiess D, Speel EJ, Winnepenninckx V, Diaz C, Weyers W, Haugg AM, Kurz AK, Zur HA. Frequent detection of human polyomavirus 6 in keratoacanthomas. Diagn Pathol. 2016;11:58.PubMedPubMedCentralCrossRef
63.
Bergallo M, Daprà V, Fava P, Ponti R, Calvi C, Montanari P, Novelli M, Quaglino P, Galliano I, Fierro MT. DNA from human polyomaviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in cutaneous T-cell lymphomas. Anticancer Res. 2018;38:4111–4.PubMedCrossRef
64.
Purdie KJ, Proby CM, Rizvi H, Griffin H, Doorbar J, Sommerlad M, Feltkamp MC, der Meijden EV, Inman GJ, South AP, et al. The role of human papillomaviruses and polyomaviruses in BRAF-inhibitor induced cutaneous squamous cell carcinoma and benign squamoproliferative lesions. Front Microbiol. 2018;9:1806.PubMedPubMedCentralCrossRef
65.
Antonsson A, Bialasiewicz S, Rockett RJ, Jacob K, Bennett IC, Sloots TP. Exploring the prevalence of ten polyomaviruses and two herpes viruses in breast cancer. PLoS ONE. 2012;7:e39842.PubMedPubMedCentralCrossRef
66.
Du-Thanh A, Guillot B, Dereure O, Foulongne V. Detection of Merkel cell and other human polyomavirus DNA in lesional and nonlesional skin from patients with Kaposi sarcoma. Br J Dermatol. 2015;173:1063–5.PubMedCrossRef
67.
Rennspiess D, Pujari S, Keijzers M, Abdul-Hamid MA, Hochstenbag M, Dingemans AM, Kurz AK, Speel EJ, Haugg A, Pastrana DV, et al. Detection of human polyomavirus 7 in human thymic epithelial tumors. J Thorac Oncol. 2015;10:360–6.PubMedPubMedCentralCrossRef
68.
Klufah F, Mobaraki G, Chteinberg E, Alharbi RA, Winnepenninckx V, Speel EJM, Rennspiess D, Olde Damink SW, Neumann UP, Kurz AK, et al. High prevalence of human polyomavirus 7 in cholangiocarcinomas and adjacent peritumoral hepatocytes: preliminary findings. Microorganisms. 2020;8:1125.PubMedCentralCrossRef
69.
Chan JF, Tee KM, Choi GK, Zhu Z, Poon RW, Ng KT, Chan KH, Hung IF, Man K, Yuen KY. First detection and complete genome sequence of a phylogenetically distinct human polyomavirus 6 highly prevalent in human bile samples. J Infect. 2017;74:50–9.PubMedCrossRef
70.
Bendiksen S, Rekvig OP, Van Ghelue M, Moens U. VP1 DNA sequences of JC and BK viruses detected in urine of systemic lupus erythematosus patients reveal no differences from strains expressed in normal individuals. J Gen Virol. 2000;81:2625–33.PubMedCrossRef
71.
Taguchi F, Hara K, Kajioka J, Nagaki D. Isolation of BK virus from a patient with systemic lupus erythematosus (SLE). Microbiol Immunol. 1979;23:1131–2.PubMedCrossRef
72.
Chang D, Tsai RT, Wang M, Ou WC. Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan. J Med Virol. 1996;48:204–9.PubMedCrossRef
73.
Rekvig OP, Moens U, Sundsfjord A, Bredholt G, Osei A, Haaheim H, Traavik T, Arnesen E, Haga HJ. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Investig. 1997;99:2045–54.PubMedCrossRefPubMedCentral
74.
Sundsfjord A, Osei A, Rosenqvist H, Van Ghelue M, Silsand Y, Haga HJ, Rekvig OP, Moens U. BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis. 1999;180:1–9.PubMedCrossRef
75.
Colla L, Mesiano P, Morellini V, Besso L, Cavallo R, Bergallo M, Costa C, Merlino C, Marcuccio C, Fop F, et al. Human polyomavirus BK in patients with lupus nephritis: clinical and histological correlations. Lupus. 2007;16:881–6.PubMedCrossRef
76.
Stoner GL, Agostini HT, Ryschkewitsch CF, Komoly S. JC virus excreted by multiple sclerosis patients and paired controls from Hungary. Multiple Scler. 1998;4:45–8.CrossRef
77.
Bellizzi A, Anzivino E, Rodio DM, Cioccolo S, Scrivo R, Morreale M, Pontecorvo S, Ferrari F, Di Nardo G, Nencioni L, et al. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. Virol J. 2013;10:298.PubMedPubMedCentralCrossRef
78.
Lonergan RM, Carr MJ, De Gascun CF, Costelloe LF, Waters A, Coughlan S, Duggan M, Doyle K, Jordan S, Hutchinson MW, et al. Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy. J Neurovirol. 2009;15:351–9.PubMedCrossRef
79.
Delbue S, Elia F, Carloni C, Pecchenini V, Franciotta D, Gastaldi M, Colombo E, Signorini L, Carluccio S, Bellizzi A, et al. JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients. J Neurovirol. 2015;21:645–52.PubMedCrossRef
80.
Pietropaolo V, Bellizzi A, Anzivino E, Iannetta M, Zingaropoli MA, Rodio DM, Morreale M, Pontecorvo S, Francia A, Vullo V, et al. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment. J Neurovirol. 2015;21:653–65.PubMedPubMedCentralCrossRef
81.
Nali LH, Fink MC, do Olival GS, Moraes L, Callegaro D, Tilbery CP, Vidal JE, Sumita LM, de Oliveira AC, Romano CM. Polyomavirus detection in multiple sclerosis patients under natalizumab therapy: profile and frequency of urinary shedding. J Med Virol. 2017;89:528–34.PubMedCrossRef
82.
Dolci M, Favero C, Bollati V, Campo L, Cattaneo A, Bonzini M, Villani S, Ticozzi R, Ferrante P, Delbue S. Particulate matter exposure increases JC polyomavirus replication in the human host. Environ Pollut. 2018;241:234–9.PubMedCrossRef
83.
Rockett RJ, Sloots TP, Bowes S, O’Neill N, Ye S, Robson J, Whiley DM, Lambert SB, Wang D, Nissen MD, et al. Detection of novel polyomaviruses, TSPyV, HPyV6, HPyV7, HPyV9 and MWPyV in feces, urine, blood, respiratory swabs and cerebrospinal fluid. PLoS ONE. 2013;8:e62764.PubMedPubMedCentralCrossRef
84.
Torres C, Barrios ME, Cammarata RV, Cisterna DM, Estrada T, Martini Novas S, Cahn P, Blanco Fernández MD, Mbayed VA. High diversity of human polyomaviruses in environmental and clinical samples in Argentina: detection of JC, BK, Merkel-cell, Malawi, and human 6 and 7 polyomaviruses. Sci Total Environ. 2016;542:192–202.PubMedCrossRef
85.
Hashida Y, Higuchi T, Tanaka M, Shibata Y, Nakajima K, Sano S, Daibata M. Prevalence and viral loads of cutaneous human polyomaviruses in the skin of patients with chronic inflammatory skin diseases. J Infect Dis. 2019;219:1564–73.PubMedCrossRef
86.
Markowitz RB, Eaton BA, Kubik MF, Latorra D, McGregor JA, Dynan WS. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol. 1991;65:4515–9.PubMedPubMedCentralCrossRef
87.
Chang D, Wang M, Ou WC, Lee MS, Ho HN, Tsai RT. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan. J Med Virol. 1996;48:95–101.PubMedCrossRef
88.
Boldorini R, Veggiani C, Amoruso E, Allegrini S, Miglio U, Paganotti A, Ribaldone R, Monga G. Latent human polyomavirus infection in pregnancy: investigation of possible transplacental transmission. Pathology. 2008;40:72–7.PubMedCrossRef
89.
Kling CL, Wright AT, Katz SE, McClure GB, Gardner JS, Williams JT, Meinerz NM, Garcea RL, Vanchiere JA. Dynamics of urinary polyomavirus shedding in healthy adult women. J Med Virol. 2012;84:1459–63.PubMedPubMedCentralCrossRef
90.
Csoma E, Sápy T, Mészáros B, Gergely L. Novel human polyomaviruses in pregnancy: higher prevalence of BKPyV, but no WUPyV, KIPyV and HPyV9. J Clin Virol. 2012;55:262–5.PubMedCrossRef
Metadata
Title
HPyV6 and HPyV7 in urine from immunocompromised patients
Authors
Carla Prezioso
Marijke Van Ghelue
Ugo Moens
Valeria Pietropaolo
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2021
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-021-01496-1

Other articles of this Issue 1/2021

Virology Journal 1/2021 Go to the issue

Research

Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients

Research

A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine

Research

Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China

Research

Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout

Research

Analysis of the intestinal microbial community altered during rotavirus infection in suckling mice

Commentary

Further considerations about “Detection and identification of enteroviruses circulating in children with acute gastroenteritis in Pará State, Northern Brazil (2010–2011)”
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits